Covered recipient · General Payments record
RAHUL KHURANA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$175,573.71
- Reported across 158 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $14,045.83 | 8 |
| Food and Beverage | $412.61 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $6,783.20 | 5 |
| ABBVIE INC. | $3,895.83 | 3 |
| Genentech, Inc. | $2,520.00 | 1 |
| Bausch & Lomb Americas Inc. | $1,021.66 | 2 |
| Alcon Laboratories Inc | $123.73 | 1 |
| RxSight Inc | $114.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1,356.25 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103136185 | CMS |
| ABBVIE INC. | $839.58 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103136187 | CMS |
| ABBVIE INC. | $1,700.00 | 12/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103136189 | CMS |
| Alcon Vision LLC | $123.73 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110599825 | CMS |
| Bausch & Lomb Americas Inc. | $1,000.00 | 11/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140429788 | CMS |
| Bausch & Lomb Americas Inc. | $21.66 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140429790 | CMS |
| Genentech, Inc. | $2,520.00 | 10/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133091815 | CMS |
| Regeneron Pharmaceuticals, Inc. | $21.82 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114400969 | CMS |
| Regeneron Pharmaceuticals, Inc. | $1,105.00 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114400971 | CMS |
| Regeneron Pharmaceuticals, Inc. | $131.38 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114400973 | CMS |
| Regeneron Pharmaceuticals, Inc. | $2,210.00 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114400975 | CMS |
| Regeneron Pharmaceuticals, Inc. | $3,315.00 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114400977 | CMS |
| RxSight Inc | $114.02 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144219602 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.